Association between somatostatin analogues and diabetes mellitus in gastroenteropancreatic neuroendocrine tumor patients: A Surveillance, Epidemiology, and End Results‐Medicare analysis of 5235 patients

BACKGROUND: Gastroenteropancreatic neuroendocrine tumors (GEP‐NETs) are increasingly common malignancies and tend to have favorable long‐term prognoses. Somatostatin analogues (SSA) are a first‐line treatment for many NETs. Short‐term experiments suggest an association between SSAs and hyperglycemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Katherine, Yang, Jeong Yun, Baeg, Kiwoon, Leiter, Amanda C., Mhango, Grace, Gallagher, Emily J., Wisnivesky, Juan P., Kim, Michelle K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551991/
https://www.ncbi.nlm.nih.gov/pubmed/33835729
http://dx.doi.org/10.1002/cnr2.1387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551991/
https://www.ncbi.nlm.nih.gov/pubmed/33835729
http://dx.doi.org/10.1002/cnr2.1387

Ejemplares similares